You are here: Home / Where We Work / Indonesia

Syane Luntungan/Jhpiego

Indonesia

Started: December 2016

To help inform the efforts of the Government of Indonesia and development partners to reduce the country’s maternal and newborn mortality, USAID will support the Indonesian Academy of Sciences (Akademi Ilmu Pengetahuan Indonesia- AIPI) to convene the first-ever Indonesia Maternal and Newborn Health Evidence Summit. A report published in 2013 — “Reducing Maternal and Neonatal Mortality in Indonesia: Saving Lives, Saving the Future” — was developed through a collaboration between AIPI and the US National Academy of Sciences, also supported by USAID. That report provided an authoritative analysis of maternal and neonatal health issues in Indonesia and high level recommendations.

The Indonesia-specific Maternal and Neonatal Health Evidence Summit builds on the 2013 report and applies, for the first time, the global USAID Evidence Summit methodology at an individual country level. This activity is envisioned to be the first step in an ongoing process of evidence review, formulation of recommendations for policymakers, and priority setting in Indonesia that will continue for many years. The Evidence Summit is expected to provide a platform for bringing all interested parties together to set priorities for action to improve maternal and newborn health in Indonesia. And, being the first time that such an event has been conducted at the country level, it will also serve as a model for other countries.

In addition to supporting AIPI to conduct the summit, MCSP is working with the University of Indonesia to implement a study of maternal and newborn mortality in Banten province. Called the Banten II study, it is intended to measure and compare maternal mortality in three study districts in Banten province to assess how maternal mortality has changed since the Banten I study was conducted in 2006. The study will also develop and pilot the addition of a newborn mortality study methodology in two sub-districts. It is expected that the results of the Banten II study will provide important, new evidence to the Evidence Summit activity.

Evidence Summit background documents:

Intervention Areas:

Country Data


MCSP analyzed coverage disparities across RMNCH indicators for MCSP program countries. Click below for country-specific data.

Download File

Indonesia 2017 Graph
Source: USAID’s 2017 “Acting on the Call” report
Maternal Child Survival Program
Maternal and Child Survival Program